Polymorphic form of a tachykinin receptor antagonist

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514132, A61K 31535, C07D41306

Patent

active

054571073

ABSTRACT:
This invention is concerned with a novel polymorphic form of the compound 2-(S)-(3,5-bis(trifluoromethyl)benzyloxy)-4-(3-(5-oxo-1H,4H-1,2,4-triazolo )methyl)-3-(S)-phenyl-morpholine which is a tachykinin receptor antagonist useful in the treatment of inflammatory diseases, pain or migraine, asthma, and emesis.
The instant polymorphic form has advantages over the other known forms of 2-(S)-(3,5-bis(trifluoromethyl)benzyloxy)-4-(3-(5-oxo-1H,4H-1,2,4-triazolo )methyl)-3-(S)-phenyl-morpholine in terms of thermodynamic stability and suitability for inclusion in pharmaceutical formulations.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Polymorphic form of a tachykinin receptor antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polymorphic form of a tachykinin receptor antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymorphic form of a tachykinin receptor antagonist will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2310560

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.